TerrAscend (TSNDF) Capital Leases (2021 - 2024)

TerrAscend's (TSNDF) quarterly Capital Leases came in at $2.1 million in Q2 2024, little changed year-on-year from $2.1 million in Q3 2023, and up 458.75% on a QoQ basis from $383000.0 in Q1 2024.

TerrAscend (TSNDF) Capital Leases (2021 - 2024) Analysis & Trends

TerrAscend (TSNDF) has 4 years of Capital Leases data on file, last reported at $2.1 million in Q2 2024.

  • On a quarterly basis, Capital Leases changed 0.05% year-over-year to $2.1 million in Q2 2024; TTM through Jun 2024 was $2.1 million, a 0.05% change from a year earlier, with the FY2023 full-year figure at $407000.0, down 93.94% from the prior year.
  • Capital Leases for Q2 2024 stood at $2.1 million, up from $383000.0 in the prior quarter.
  • Over the last five years, Capital Leases for TSNDF reached as high as $6.7 million in Q4 2022 and fell as low as $181000.0 in Q4 2021.
  • Historically, Capital Leases has averaged $2.9 million across 4 years, with a median of $2.1 million in 2023.
  • Across the five-year window, Capital Leases surged 3608.84% in 2022 and slumped 94.21% in 2024, its largest moves.
  • Year by year, Capital Leases stood at $181000.0 in 2021, then jumped by 3608.84% to $6.7 million in 2022, then sank by 93.94% to $407000.0 in 2023, then soared by 425.8% to $2.1 million in 2024.
  • Per Business Quant data, the three most recent Capital Leases figures were $2.1 million in Q2 2024, $383000.0 in Q1 2024, and $407000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 2.14 Mn
Mar 31, 2024 383,000.00
Dec 31, 2023 407,000.00
Sep 30, 2023 571,000.00
Jun 30, 2023 2.14 Mn
Mar 31, 2023 6.61 Mn
Dec 31, 2022 6.71 Mn
Sep 30, 2022 4.70 Mn
Jun 30, 2022 4.79 Mn
Dec 31, 2021 181,000.00